Literature DB >> 8528564

The effect of folate on the methotrexate/indomethacin interaction in a murine cancer cell line.

S J Hollingsworth1, E M Anderson, A Bennett.   

Abstract

1. The effect of folate on the interaction between methotrexate (a folate analogue) and indomethacin has been examined in murine NC carcinoma cells. 2. Conditioning of NC cells to a physiological (20 nM) folate concentration after culture in a high folate concentration increased the response to methotrexate. The sensitivity of these conditioned cells to methotrexate related inversely to the folate concentration. 3. At 20 nM and 2 microM folate, indomethacin 1 micrograms ml-1 potentiated the cytotoxicity of methotrexate 4 and 8 ng ml-1 (both P < 0.03). 4. When NC cells were incubated with [3H]-methotrexate at 20 nM and 2 microM folate, there was a trend for increased tritium accumulation with indomethacin 0.36 micrograms ml-1 (1 microM; P < 0.01). 5. We conclude that the folate concentration can affect the sensitivity of NC cells to methotrexate, although the degree of potentiation of cytotoxicity by indomethacin remains similar.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528564      PMCID: PMC1909078          DOI: 10.1111/j.1476-5381.1995.tb16667.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase.

Authors:  H S Kantor; M Hampton
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

2.  Modulation of methotrexate cytotoxicity with natural interferon upon human leukemia cell line HL-60.

Authors:  P Sur; Y Matsuo; T Otani; J Minowada
Journal:  Oncology       Date:  1991       Impact factor: 2.935

3.  Effect of indomethacin on arachidonic acid metabolism in human leukocytes stimulated ex vivo.

Authors:  J C Docherty; T W Wilson
Journal:  Clin Pharmacol Ther       Date:  1991-03       Impact factor: 6.875

4.  Cyclic adenosine 3':5'-monophosphate and methotrexate transport in L1210 cells.

Authors:  G B Henderson; E M Zevely; F M Huennekens
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

5.  Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.

Authors:  R D Maca
Journal:  Anticancer Drug Des       Date:  1991-11

6.  Polygammaglutamyl metabolites of methotrexate.

Authors:  C M Baugh; C L Krumdieck; M G Nair
Journal:  Biochem Biophys Res Commun       Date:  1973-05-01       Impact factor: 3.575

7.  AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.

Authors:  G Weber; M Nagai; N Prajda; H Nakamura; T Szekeres; E Olah
Journal:  Cancer Commun       Date:  1991-04

8.  Cardiovascular effects of substituted tetrahydroisoquinolines in rats.

Authors:  H Dong; C M Lee; W L Huang; S X Peng
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

9.  Methotrexate alters the fatty acid composition of NC adenocarcinoma cells in culture.

Authors:  Z Yazici; I A Tavares; A S Soydan; S J Hollingsworth; P M Bishai; A Bennett
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

10.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.